Modulator
AssigneeCanbex Therapeutics Limited
InventorsMasahiro OKUYAMA, David SELWOOD, Cristina VISINTIN, David BAKER, Gareth PRYCE
Life of this patent
Estimating the term…
Loading patent…
AssigneeCanbex Therapeutics Limited
InventorsMasahiro OKUYAMA, David SELWOOD, Cristina VISINTIN, David BAKER, Gareth PRYCE
Estimating the term…
The present disclosure relates to a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein Z is selected from OH, NHCH2CH2F, NHCH(Me)CH2OH and NHCH2CH2OH; X is an alkylene, alkenylene, or alkynylene group, each of which may be optionally substituted by one or more substituents selected from alkyl, COOH, CO2-alkyl, alkenyl, CN, NH2, hydroxy, halo, alkoxy, CF3 and nitro; Y is a polar functional group selected from OH, NO2, CN, COR3, COOR3, NR3R4, CONR3R4, SO3H, SO2—R3, SO2NR3R4 and CF3, where each of R3 and R4 is independently H or a hydrocarbyl group; A is phenyl or pyridyl; and B is (CH2)n where n is 0; with the proviso that: (i) when A is phenyl, and Z is OH, X—Y is other than C≡C—(CH2)2CO2H, C≡C—(CH2)2CO2Me, (CH2)4CO2H. Uses of such compounds as medicaments for the treatment of a muscular disorder, a gastrointestinal disorder, or for controlling spasticity or tremors are provided.
A compound of formula I, or a pharmaceutically acceptable salt thereof,
Dependencies are inferred from the claim text.